Giuseppe Andò: Stable CAD + Oral Anticoagulation: Is Combination Therapy Still Justified?
Giuseppe Andò, Head of the Cardiology Department at Papardo University Hospital, shared on LinkedIn:
” Stable CAD + Oral Anticoagulation: Is Combination Therapy Still Justified?
For years, adding antiplatelet therapy to oral anticoagulation has been considered “safer.”
The evidence no longer supports this approach.
In the post-AQUATIC era, leveraging data from a large European RCT that expanded indications for OAC beyond atrial fibrillation, we conducted an updated meta-analysis of 6 randomized trials (n = 5,924) comparing OAC monotherapy vs OAC + SAPT in stable coronary artery disease.
OAC monotherapy delivers:
−51% major bleeding
Lower net adverse clinical events
Reduced cardiovascular mortality
No increase in ischemic events
Even more compelling: DOAC-based monotherapy significantly reduced MACE, with a clear treatment interaction.
Bottom line:
In patients with stable CAD requiring long-term anticoagulation, less is more.
OAC monotherapy—particularly with DOACs—should be the default strategy, especially in East Asian populations.
After AQUATIC, continuing routine combination therapy deserves serious reconsideration.”
Title: Oral anticoagulation with versus without antiplatelet therapy in patients with stable coronary artery disease and an indication for anticoagulation: a meta-analysis with trial sequential analysis
Authors: Ahmed Ibrahim, Ali Saad Al-Shammari, Shrouk Ramadan, Yousif Hameed Kurmasha, Khadeeja Ali Hamzah, M Rafiqul Islam, Muhammad Younas, Hritvik Jain, Yasar Sattar, Pierre Sabouret and Giuseppe Andò.
Read the full article.
Stay updated with Hemostasis Today.
-
Apr 7, 2026, 19:17Anand Padmanabhan: Persistence and Pathogenicity of Platelet Factor 4 Antibodies in VITT
-
Apr 7, 2026, 19:07Clara Meijs: Great Time Presenting Our Endometriosis Project at the AHA EPI Lifestyle Conference
-
Apr 7, 2026, 18:18Vivek Das: How Obesity, Type 2 Diabetes, and Dyslipidaemia Interact Across Multiple Cardiovascular Conditions
-
Apr 7, 2026, 17:44Augustina Isioma Ikusemoro: Quality Indicators for Red Blood Cells in Transfusion Medicine
-
Apr 7, 2026, 17:35Nikola Grubor: In Situ Pulmonary Arterial Thrombosis Mimicking CTEPH in Eisenmenger
-
Apr 7, 2026, 17:34Pooja Choradia: vWF Breakdown in Aortic Stenosis – Anaemia and Pulmonary Relevance
-
Apr 7, 2026, 17:32Wolfgang Miesbach: Exceptional Presentation on the Role of vWF in Angiogenesis and Gut Angiodysplasia in VWD
-
Apr 7, 2026, 17:30Chokri Ben Lamine: No Routine VTE Prophylaxis for Chronically Bedridden Patients at Home
-
Apr 7, 2026, 17:28Amanda Johnson: The Stretch of Science in the History of EDS